Peptides amyloides

Patent europeic · EP0289287 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP0289287
Numer da la dumonda
EP88303803
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
27-04-1988
Publitgà
02-11-1988
Concedì
28-01-1998
Stritgà
26-04-2008
Motiv
Durada maximala cuntanschida
Classas IPC
C07K 14/575 (2006.01)
C12N 15/12 (2006.01)
G01N 33/53 (2006.01)
Prioritad
GB 8709871 27.04.1987
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 30-05-2008

    Durada maximala cuntanschida

    Published in +pat+ No 10 in 2008

  2. 30-04-1998

    Represchentant inscrit

    Representative
    Kirker & Cie SA, 122, rue de Genève, Case postale 65, 1226 Thônex (Genève)

    Published in PIDTJ No 8 in 1998

  3. 30-01-1998

    Concedì

    Published in PIDTJ No 2 in 1998

Partidas

Possessur

Amylin Pharmaceuticals, Inc.

AMYLIN PHARMACEUTICALS, INC.

9373 Towne Centre Drive, Suite 250, San Diego California 92121, US

Represchentant

Kirker & Cie SA

122, rue de Genève Case postale 65, 1226 Thônex (Genève)

Inventur

Cooper, Garth James Smith

Woodstock Oxon. OX7 1SR, GB

Willis, Anthony Charles

Witney Oxon. OX7 1SR, GB

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.